Skip to main content
Signal8

Disc Medicine, Inc. (IRON)

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Disc Medicine, Inc. logo

Disc Medicine, Inc.

NASDAQ:IRONHealthcare
-4.26%$76.59
CLOSED
AH$76.59+0.00%vs close
Mkt Cap$3.49B
EV-
Float32.73M
O/S45.54M
VOL817K sh
$ Vol$63.41M
RVOL0.49×
Inst Own97.4%
SI21.0%
Net Cash/Sh-
Dilution
Disc Medicine, Inc. logoNASDAQ:IRONClosed$76.59-4.26%
Historical Data
DateOpenHighLowCloseVolume
Nov 16, 202680.1280.3776.4076.59817,338
Nov 13, 202683.0083.0079.7380.00779,947
Nov 12, 202686.1687.1482.6683.23761,217
Nov 11, 202685.2487.5183.5087.08669,028
Nov 10, 202680.5886.2680.5384.641,925,578
Nov 9, 202680.8381.5476.8681.26912,032
Nov 6, 202678.6579.5277.6778.91717,552
Nov 5, 202683.0085.0078.3178.47932,690
Nov 4, 202681.5083.5780.7883.281,428,090
Nov 3, 202679.4181.7279.0881.161,543,756
Nov 2, 202680.9981.6978.0478.62525,364
Oct 30, 202682.7983.0378.6180.84684,975
Oct 29, 202683.5185.0082.2282.84688,358
Oct 28, 202678.8883.6478.8883.201,100,516
Oct 27, 202677.2380.5076.5079.901,469,726
Oct 26, 202674.8078.0374.8077.661,222,038
Oct 23, 202674.2975.5674.0074.511,963,100
Oct 22, 202675.2578.0074.7775.031,588,206
Oct 21, 202677.8081.5075.8976.004,639,550
Oct 20, 202679.2180.0074.5279.482,206,622
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target (median, last 90d)
$120.00+56.7%
Low $92High $170
Ratings Distribution
BUY
11
HOLD
0
SELL
0
TOTAL11
Insider Trades
InsiderTypeShares
Savage William Jacob profile photoSavage William JacobSale16.0K
Bitterman Kevin profile photoBitterman KevinSale266
Bitterman Kevin profile photoBitterman KevinSale13.8K
Bitterman Kevin profile photoBitterman KevinSale11.5K
Bitterman Kevin profile photoBitterman KevinSale55
Bitterman Kevin profile photoBitterman KevinSale2.4K
Shareholders
97.4%
Institutional
(239)
1.3%
Insiderⓘ
(6)
10.4%
5%+ Owners
(3)
-
Unattributed (incl. retail)ⓘ
Institutional97.4%
Insider1.3%
5%+ Beneficial10.4%
Sources: 13F, Form 4, 13D/13GO/S: 45.5M · as of 29 Oct 2026 · SEC cover page
Insiders & Institutional Holders
About

Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company.

Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases.

The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.

Key Metrics
Market Cap$3.49B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership97.36%

based on 45.54M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
CountryUSUS
IPO DateAug 12, 2020
Shares Outstanding45.54M
Authorized Shares
Float32.73M
52-Week Range
$40.00$99.50
$76.59(61st percentile)
Volume
Average Daily Volume1.67M
817.34K today vs 1.67M avg(-51%)

30d Avg

1.67M

60d Avg

1.16M

90d Avg

950.79K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

3 insiders reported 28 open-market sales of IRON stock on Form 4 in the 90 days to Nov 17, 2026. Disc Medicine, Inc. (NASDAQ: IRON) traded at $76.59 on Nov 16, 2026, down 4.26% from the previous close of $80.00. 52-week range: $40.00 to $99.50. The company is in the Healthcare sector (Biotechnology).